$38.89 -0.41 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - New York Stock Exchange, Inc.

Jan. 18, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Trump + Stocks: The Week In Review

    TalkMarkets | Jan. 13, 2017 | 19:44PM EST
  2. Last London Letter

    TalkMarkets | Jan. 7, 2017 | 17:03PM EST
  3. Mylan, Novartis, Hikma Take On GSK In Generic Asthma Battle

    Investors Business Daily | Jan. 5, 2017 | 13:31PM EST
  4. Merck (MRK) Does Well In 2016: Reasons For Outperformance

    TalkMarkets | Jan. 1, 2017 | 18:09PM EST
  5. These 8 Top Dividend Stocks Are Also ADRs - Check Them Out

    TalkMarkets | Dec. 13, 2016 | 08:00AM EST
  6. BP: Asset Sales, New Projects Fuel Its 6.7% Dividend Yield

    TalkMarkets | Dec. 6, 2016 | 14:20PM EST
  7. GlaxoSmithKline: Robust Pipeline Supports its 5.5% Dividend Yield

    TalkMarkets | Dec. 4, 2016 | 11:46AM EST
  8. GSK: Robust Pipeline Supports its 5.5% Dividend Yield

    TalkMarkets | Dec. 4, 2016 | 11:46AM EST
  9. Better Than The Maestro

    TalkMarkets | Nov. 28, 2016 | 23:53PM EST
  10. 6 Worthy Dividend Stocks Down 10% Or More

    TalkMarkets | Nov. 24, 2016 | 03:57AM EST
  11. Musings And Global Markets

    TalkMarkets | Nov. 12, 2016 | 16:28PM EST
  12. Trump Triumphs

    TalkMarkets | Nov. 9, 2016 | 21:28PM EST
  13. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  14. Week In Review: China Healthcare And Pharma Deals

    TalkMarkets | Oct. 22, 2016 | 14:05PM EST
  15. Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al

    TalkMarkets | Oct. 21, 2016 | 19:05PM EST
  16. Week In Review: China Resources Pharma To Price $2 Billion Hong Kong IPO This Week

    TalkMarkets | Oct. 15, 2016 | 14:42PM EST
  17. Seven Sources of Competitive Advantage

    TalkMarkets | Oct. 9, 2016 | 15:31PM EST
  18. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets | Sep. 26, 2016 | 12:20PM EST
  19. Alphabet-Glaxo Joint Venture Targets 'Bioelectronics'

    Investors Business Daily | Aug. 1, 2016 | 09:13AM EST
  20. Veeva Is Key Partner In Big Pharma's Race Against The Clock

    Investors Business Daily | Jul. 29, 2016 | 07:00AM EST
  21. Stock Futures Up, Gaining Strength; Apple Hauls Techs Higher

    Investors Business Daily | Jul. 27, 2016 | 07:00AM EST
  22. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  23. Getting to Know VBI Vaccines

    GuruFocus | Jul. 13, 2016 | 12:04PM EST
  24. Brandes Makes a Variety of Reductions in 4th Quarter

    GuruFocus | Feb. 11, 2016 | 18:19PM EST
  25. Stock Futures Up As Oil Behaves; Syngenta Up On ChemChina Deal

    IBD | Feb. 3, 2016 | 09:03AM EST
  26. EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4

    Benzinga | Jan. 29, 2016 | 13:38PM EST
  27. Benzinga's M&A Chatter for Thursday January 28, 2015

    Benzinga | Jan. 28, 2016 | 23:27PM EST
  28. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  29. Stocks Bring High Dividend Yields to HOTCHKIS & WILEY

    GuruFocus | Jan. 14, 2016 | 12:05PM EST
  30. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 15:40PM EST
  31. Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial

    IBD | Jan. 7, 2016 | 14:51PM EST
  32. Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line

    GuruFocus | Jan. 4, 2016 | 17:46PM EST
  33. Cisco Systems, Microsoft and Intel Bring High Dividend Yields to First Eagle Investment

    GuruFocus | Jan. 4, 2016 | 14:02PM EST
  34. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  35. High Dividend Yield Ratios Are Hallmarks of Many Dodge & Cox Stakes

    GuruFocus | Dec. 21, 2015 | 10:58AM EST
  36. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD | Dec. 18, 2015 | 14:05PM EST
  37. John Rogers' Holdings Trading Below Peter Lynch Earnings Line

    GuruFocus | Dec. 16, 2015 | 16:40PM EST
  38. 3 Global Investment Ideas From Gurus

    GuruFocus | Dec. 10, 2015 | 14:57PM EST
  39. Relypsa Stock Jumps On Buyout Rumors

    IBD | Dec. 4, 2015 | 15:31PM EST
  40. Skin Disease Drug Costs Jump

    IBD | Nov. 25, 2015 | 18:34PM EST
  41. Valeant, Glaxo, Novartis Skin Drug Prices Have Soared

    IBD | Nov. 25, 2015 | 17:01PM EST
  42. Dodge & Cox Sells Most of Stakes in Chevron, GlaxoSmithKline

    GuruFocus | Nov. 17, 2015 | 18:46PM EST
  43. 3 Investment Ideas of Ariel Investment's Rupal Bhansali

    GuruFocus | Nov. 16, 2015 | 09:57AM EST
  44. Pfizer to Create a New Pharmaceutical Colossus

    GuruFocus | Nov. 5, 2015 | 13:20PM EST
  45. GlaxoSmithKline

    IBD | Oct. 28, 2015 | 17:47PM EST
  46. Gilead Beats Q3 Estimates As HIV Franchise Shines

    IBD | Oct. 27, 2015 | 16:03PM EST
  47. ISIS Pharmaceuticals Earns $5M from GSK for Initiation of Phase 1 Study of ISIS-GSK4-L Rx

    Benzinga | Oct. 26, 2015 | 06:03AM EST
  48. Benzinga's Top Upgrades

    Benzinga | Oct. 20, 2015 | 08:11AM EST
  49. IBM, Schlumberger PTs Lowered; Valeant Downgraded

    IBD | Oct. 20, 2015 | 07:38AM EST
  50. GlaxoSmithKline Has a High (and Dangerous) Dividend Yield

    GuruFocus | Oct. 19, 2015 | 13:32PM EST
Trading Center